509 results on '"Hanash S"'
Search Results
2. Validation of a blood-based sphingolipid panel for men with prostate cancer on active surveillance
3. Impact des comorbidités respiratoires sur les résultats du dépistage organisé du cancer broncho-pulmonaire
4. EP02.03-03 The Functional and Mechanistic Role of PA28α in Lung Cancer
5. P1.24-02 Mortality Benefit of a 4-Protein Blood-Based Biomarker Panel for Lung Cancer
6. Surfaceome profiling enables isolation of cancer-specific exosomal cargo in liquid biopsies from pancreatic cancer patients
7. Quantitative Proteomic Profiling Identifies Protein Correlates to EGFR Kinase Inhibition
8. Mortality Benefit of a Blood-based Biomarker Panel for Lung Cancer Based on the PLCO Cohort
9. Kynureninase Upregulation Is a Feature of NRF2-upregulated Lung Cancers and Is Associated With Tumor Immunosuppression and Poorer Prognosis
10. High prevalence of mutantKRAS in circulating exosome-derived DNA from early-stage pancreatic cancer patients
11. Principales causes de morbi-mortalité chez les participants à un programme de dépistage organisé du cancer bronchopulmonaire (Étude Lumascan)
12. A Methylated Human 9-kb Repetitive Sequence on Acrocentric Chromosomes is Homologous to a Subtelomeric Repeat in Chimpanzees
13. Dépistage organisé du cancer du poumon en France : acceptabilité et impact sur le sevrage tabagique : 4 ans d’expérience du programme LunaScan
14. Proteolytic Activity in Erythrocyte Precursors
15. Highly Resolving Two-Dimensional Gels for Protein Sequencing
16. Similarity of Spontaneous Germinal and in vitro Somatic Cell Mutation Rates in Humans: Implications for Carcinogenesis and for the Role of Exogenous Factors in "Spontaneous" Germinal Mutagenesis
17. Data Base Analysis of Protein Expression Patterns During T-Cell Ontogeny and Activation
18. Mice Homozygous for Chromosomal Deletions at the Albino Locus Region Lack Specific Polypeptides in Two-Dimensional Gels
19. Two-Dimensional Electrophoresis of Plasma Polypeptides Reveals ``High'' Heterozygosity Indices
20. Supplement to: ST2 as a marker for risk of therapy-resistant graftversus-host disease and death
21. Making sense of microarray data to classify cancer
22. A novel CD4+CD146+CCR5+ T-cell population is a biomarker of intestinal graft-versus-host disease: O390
23. Arcuate Nucleus Transcriptome Profiling Identifies Ankyrin Repeat and Suppressor of Cytokine Signalling Box-Containing Protein 4 as a Gene Regulated by Fasting in Central Nervous System Feeding Circuits
24. Multi-dimensional liquid phase based separations in proteomics
25. Assessment of lung cancer risk based on a biomarker panel of circulating proteins
26. Dépistage du cancer du poumon : forte prévalence d’une obstruction bronchique et de calcifications coronariennes
27. Stage III gene expression profiles identify a poor prognosis subgroup of stage I lung adenocarcinomas
28. Abnormal Expression of Immune Function Genes in B Cell Lines from ICF Syndrome Patients with Known Mutations in DNA Methyltransferase 3B Alleles
29. Elevated proliferating cell nuclear antigen levels in immature thymocytes. Dissociation from cell cycle progression
30. Circulating protein biomarker discovery strategies using mass spectrometry for cancer early detection applications
31. Abstract P5-01-09: Early tumor antigens discovered in TgMMTV-neu mice may provide targets for early breast cancer diagnosis and prevention
32. Integration of proteomics into systems biology of cancer
33. Plasma Concentration of Suppressor of Tumorigenicity 2 (ST2), the IL33 Receptor, at Initiation of Graft Versus Host Disease Therapy Predicts Day 28 Response and Day 180 Survival Post-Treatment
34. Reg3α Is a Biomarker of Graft Versus Host Disease of the Gastrointestinal Tract
35. A Three Biomarker Panel at Days 7 and 14 Can Predict Development of Grade II-IV Acute Graft-Versus-Host Disease
36. Mining the Plasma Proteome for Disease Applications Across Seven Logs of Protein Abundance
37. 619 Blood based breast cancer molecular signatures
38. Application of proteomics to cancer epidemiology
39. CEACAM1 IS A BIOMARKER FOR PANCREATIC CANCER.
40. Aging Is Associated With Increased T-Cell Chemokine Expression in C57Bl/6 Mice
41. Contributions of Proteome Profiling to the Molecular Analysis of Cancer
42. Operomics: Integrated genomic and proteomic profiling of cells and tissues
43. Unexpected Effects of a Heterozygous Dnmt1 Null Mutation on Age-Dependent DNA Hypomethylation and Autoimmunity
44. Analysis of human peripheral blood T cells and single-cell-derived T cell clones uncovers extensive clonal CpG island methylation heterogeneity throughout the genome
45. Differential expression of Hsp27 in normal oesophagus, Barrett’s metaplasia and oesophageal adenocarcinomas
46. Effect of mitogenic stimulation and DNA methylation on human T cell DNA methyltransferase expression and activity.
47. p53 Mutation as a Prognostic Marker in Advanced Laryngeal Carcinoma
48. Identification of amplifications, deletions and methylation changes in cancer by means of two-dimensional analysis of genomic digests: application to neuroblastoma
49. Two-Dimensional Separation and Cloning of Chromosome 1NotI–EcoRV-Derived Genomic Fragments
50. Genetic analysis of children of atomic bomb survivors.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.